MIRA (MIRA) news
Recent news
Mira Pharmaceuticals - announces positive preclinical results for oral Mira-55 - SEC filing
AInvest Wire · Jul 10, 2026Mira Pharmaceuticals - announces positive preclinical results for oral SKNY-1 - SEC filing
Mira Pharmaceuticals, Inc. (NASDAQ: MIRA) reported new preclinical findings for SKNY-1, an oral drug candidate under definitive agreement for acquisition, in a recent SEC filing on Form 8-K dated July 10, 2025. The study demonstrated that SKNY-1 reversed anxiety-related behavior in a validated…
AInvest Wire · Jul 6, 2026Mira Pharmaceuticals secures worldwide exclusive rights to Mira-55 and SKNY-1 - SEC filing
AInvest Wire · Jun 4, 2026San Diego apartment investors group 31 LLC raises $6.35M; offering $6.35M
A San Diego-based apartment investment group, 31 LLC, has recently raised $6.35 million in equity financing to support its multifamily real estate activities in the region. The capital will be used to facilitate new acquisitions and expand the group’s portfolio of residential properties. This…
AInvest Wire · May 29, 2026Tapestry gets US patent for Mira AI platform
Tapestry, a project under the AI Alliance, has been awarded a U.S. patent for its AI platform, Mira according to Business Wire . The patent covers the platform's innovative technology, which is part of Tapestry's broader initiative to develop a collaborative framework for open and sovereign AI. The…
AInvest Wire · May 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.